1-(1H-吲哚-3-基)-2-(吗啉-4-基)乙烷-1,2-二酮 | 5625-89-8

• 物质功能分类: 医药中间体 - 杂环化合物 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1-(1H-吲哚-3-基)-2-(吗啉-4-基)乙烷-1,2-二酮
• 英文名称: 1-(1H-indol-3-yl)-2-(morpholin-4-yl)ethane-1,2-dione
• 英文别名: 1-(1H-indol-3-yl)-2-morpholin-4-ylethane-1,2-dione；1-(1H-indol-3-yl)-2-morpholinoethane-1,2-dione；4-(indol-3-yl-oxo-acetyl)-morpholine；4-(Indol-3-yl-glyoxyloyl)-morpholin；3-Indolylglyoxalsaeure-morpholid；1-(1H-indol-3-yl)-2-morpholin-4-yl-2-oxoethanone
• CAS: 5625-89-8
• 化学式: C₁₄H₁₄N₂O₃
• mdl: MFCD00424980
• 分子量: 258.277
• InChiKey: LMNYZFUEOJRQSR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  62.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  1-(1H-吲哚-3-基)-2-(吗啉-4-基)乙烷-1,2-二酮 在 四氢呋喃 、 lithium aluminium tetrahydride 作用下， 生成 4-(2-(1H-indol-3-yl)ethyl)morpholine
  参考文献：
  名称：

  Untersuchungen �ber Rauwolfia-Alkaloid-Modelle I

  摘要：

  DOI：

  10.1007/bf00905400
• 作为产物：
  描述：

  吲哚 在 potassium carbonate 作用下， 以 乙醚 、 乙腈 为溶剂， 反应 12.5h， 生成 1-(1H-吲哚-3-基)-2-(吗啉-4-基)乙烷-1,2-二酮
  参考文献：
  名称：

  N-1, C-3 substituted indoles as 5-LOX inhibitors—In vitro enzyme immunoaasay, mass spectral and molecular docking investigations

  摘要：

  Based upon the structures of some known 5-LOX inhibitors, a set of five compounds carrying appropriate substituents at N-1 and C-3 of indole were synthesized and investigated for 5-LOX inhibitory activities. Fifty percent inhibitory concn (IC50) of these compounds ranges from 0.6 to 5 mu M and found to be comparable to that of clinically used 5-LOX inhibitor, zileuton. The compounds under present investigations exhibited appreciable interactions with 5-LOX as apparent from their association constants calculated from the mass spectral data. Compound 5a with a tosyl group at N-1 and pyrolidinyl-1,2-dione substituent at C-3 of indole, exhibiting IC50 0.6 mu M and stoichiometry of 1:7 in the enzyme-compound complex was identified as highly potent 5-LOX inhibitor and seems to be suitable for further investigations. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.12.068

文献信息

• Calcium Ion Channel Modulators & Uses Thereof
  申请人：Khan Nawaz Mohammed

  公开号：US20110166136A1

  公开（公告）日：2011-07-07

  Compounds of formula (1), salts and pro-drugs wherein: R1, R2, R3 and R4 are hydrogen, alkyl, hydroxyalkyl, halogen, haloalkyl, alkoxy, haloalkoxy, alkoxycarbonyl, carboxyl, hydroxyl, nitro, amino, monalkylamino, dialkylamino, acylamino, alkoxycarbonylamino, alkylsulphonyl, arylsulphonyl, alkylsulphonylamino, arylsulphonylamino, aminosulphonyl or cyano, or any two of R1 to R4 that are adjacent on the ring may together represent the moiety —O—(CH 2 ) n —O— wherein n is 1 to 3; R5 is hydrogen or alkyl; R6 is hydrogen or alkyl; and X is selected from the group consisting of: (a) groups of formula OR7 wherein R7 is hydrogen or alkyl which is optionally substituted with a substituent selected from alkylsulfonylalkyl, saturated or partially unsaturated heterocyclic, alkoxy, carboxyl, nitro, amino, monalkylamino, dialkylamino, halogen, and alkoxycarbonyl, provided that when R7 is hydrogen or ethyl, then R1, R2, R3 and R4 cannot be selected from hydrogen, halogen and alkyl; and (b) groups of formula NR8R9 wherein R8 and R9 together with the nitrogen atom to which they are attached form a saturated or partially unsaturated heterocyclic group which optionally contains at least one more heteroatom selected from nitrogen, oxygen and sulphur atoms, said saturated or partially unsaturated heterocyclic group optionally further being substituted by one or more substituents selected from alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, nitro, amino, monalkylamino, dialkylamino and hydroxyl, provided that: (i) when R8+R9+N=piperazine, and ≧1 of R1 to R4 are hydrogen, hydroxyl, nitro, amino, alkylamino, dialkylamino, alkoxycarbonylamino, halogen, alkoxy or alkyl, the nitrogen atom at the 4-position of the piperazine is not alkyl substituted, (ii) when each of R1, R2, R3, R4, R5 and R6 is hydrogen, X is not unsubstituted piperazinyl or unsubstituted morpholino, (iii) when each of R1, R2, R4, R5 and R6 is hydrogen and R3 hydrogen, bromine or hydroxyl, X is not methoxy, (iv) when each of R2 and R3 is methoxy or they together represent —O—CH 2 —O— and each of R1, R4, R5 and R6 is hydrogen, X is not unsubstituted piperidine, are Cavx channel blockers and are of use in the treatment of various conditions including pain.

  公式（1）的化合物，盐和前药，其中： R1、R2、R3和R4分别为氢、烷基、羟基烷基、卤素、卤基烷基、烷氧基、卤基烷氧基、烷氧羰基、羧基、羟基、硝基、氨基、单烷基氨基、双烷基氨基、酰胺基、烷氧羰胺基、烷基磺酰基、芳基磺酰基、烷基磺酰胺基、芳基磺酰胺基、氨基磺酰基或氰基，或者相邻的R1到R4中的任意两个可以共同表示—O—（CH2）n—O—基团，其中n为1到3； R5为氢或烷基； R6为氢或烷基； X选自以下组： （a）OR7式基团，其中R7为氢或烷基，可选地被选自烷基磺酰基烷基、饱和或部分不饱和杂环、烷氧基、羧基、硝基、氨基、单烷基氨基、双烷基氨基、卤素和烷氧羰基的取代基替换，前提是当R7为氢或乙基时，R1、R2、R3和R4不能被选择为氢、卤素和烷基； （b）NR8R9式基团，其中R8和R9与它们所连接的氮原子共同形成饱和或部分不饱和的杂环基团，该杂环基团可选择地含有至少一个来自氮、氧和硫原子的其他杂原子，所述的饱和或部分不饱和的杂环基团可选择地进一步被一个或多个取代基替换，所述取代基被选自烷基、卤素、卤基烷基、烷氧基、烷氧羰基、羧基、硝基、氨基、单烷基氨基、双烷基氨基和羟基，前提是： （i）当R8+R9+N=piperazine，且R1到R4中≧1个为氢、羟基、硝基、氨基、烷基氨基、双烷基氨基、烷氧羰胺基、卤素、烷氧基或烷基时，哌嗪的4位氮原子不被烷基取代， （ii）当R1、R2、R3、R4、R5和R6都为氢时，X不是未取代的哌嗪基或未取代的吗啡环基， （iii）当R1、R2、R4、R5和R6都为氢且R3为氢、溴或羟基时，X不是甲氧基， （iv）当R2和R3都为甲氧基或它们共同表示—O—CH2—O—，且R1、R4、R5和R6都为氢时，X不是未取代的哌啶基， 它们是Cavx通道阻滞剂，可用于治疗包括疼痛在内的各种疾病。
• Sulfur rich 2-mercaptobenzothiazole and 1,2,3-triazole conjugates as novel antitubercular agents
  作者：Fauzia Mir、Syed Shafi、M.S. Zaman、Nitin Pal Kalia、Vikrant S. Rajput、Chaitanya Mulakayala、Naveen Mulakayala、Inshad A. Khan、M.S. Alam

  DOI：10.1016/j.ejmech.2014.02.017

  日期：2014.4

  A series of benzfused heterocyclic derivatives such as amide conjugates of 2-(benzo[d]thiazol-2-ylthio) acetic acid with aromatic/aliphatic/cyclic secondary amines (5a-5o & 8a-8m); 1,2,3-triazole conjugates of 2-mercaptobenzothiazoles and amide conjugates of indole-3-glyoxalic acid with cyclic secondary amines (14a-14g) have been synthesized and were screened for their antitubercular activity against Mycobacterium tuberculosis H37Rv strain by broth microdilution assay method. Compounds 8b, 8f, 8g and 8l inhibited the growth of the H37Rv strain at concentrations of 8 mu g/mL. These compounds (8b, 8f, 8g and 8l) have been further identified as bactericidal and are completely killing the microbes at 32-64 mu g/mL concentrations. Molecular docking studies of the active compounds reveal that these compounds are targeting DprE1 and may act as DprE1 inhibitors. (C) 2014 Elsevier Masson SAS. All rights reserved.
• Synthesis and evaluation of indole-based new scaffolds for antimicrobial activities—Identification of promising candidates
  作者：Palwinder Singh、Puja Verma、Bhawna Yadav、Sneha S. Komath

  DOI：10.1016/j.bmcl.2011.04.001

  日期：2011.6

  Search for new antimicrobial agents led to the synthesis of series of N-1, C-3 and C-5 substituted bis-indoles. Their evaluation for antifungal and antibacterial activities resulted in the optimization of pyrrolidine/morpholine/N-benzyl moiety at the C-3 end and propane/butane/xylidine groups as linkers between two indoles for significant inhibition of microbial growth. Preliminary investigations have identified three highly potent antimicrobial agents. Dockings of these molecules in the active sites of lanosterol demethylase, dihydrofolate reductase and topoisomerase II indicate their strong interactions with these enzymes. (C) 2011 Elsevier Ltd. All rights reserved.
• Synthesis of marine alkaloid: 8,9-Dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents
  作者：Leena Gupta、Archna Talwar、Nishi、Shraddha Palne、Suman Gupta、Prem M.S. Chauhan

  DOI：10.1016/j.bmcl.2007.04.035

  日期：2007.7

  A series of marine alkaloid 8,9-dihydrocoseinamide B, its analogues and indolylglyoxylamide derivatives have been synthesized and screened for their in vitro antileishmanial activity profile in promastigote and amastigote models. Compounds 7 and 10 have shown 99-100% inhibition against promastigotes and 97-98% inhibition against amastigotes at a concentration of 10 mu g/ml. (C) 2007 Elsevier Ltd. All rights reserved.
• Synthesis and biological activity of novel mono-indole and mono-benzofuran inhibitors of bacterial transcription initiation complex formation
  作者：Marcin Mielczarek、Ruth V. Thomas、Cong Ma、Hakan Kandemir、Xiao Yang、Mohan Bhadbhade、David StC. Black、Renate Griffith、Peter J. Lewis、Naresh Kumar

  DOI：10.1016/j.bmc.2015.02.037

  日期：2015.4

  Our ongoing research focused on targeting transcription initiation in bacteria has resulted in synthesis of several classes of mono-indole and mono-benzofuran inhibitors that targeted the essential protein-protein interaction between RNA polymerase core and sigma(70)/sigma(A) factors in bacteria. In this study, the reaction of indole-2-, indole-3-, indole-7- and benzofuran-2-glyoxyloyl chlorides with amines and hydrazines afforded a variety of glyoxyloylamides and glyoxyloylhydrazides. Similarly, condensation of 2- and 7-trichloroacetylindoles with amines and hydrazines delivered amides and hydrazides. The novel molecules were found to inhibit the RNA polymerase-sigma(70)/sigma(A) interaction as measured by ELISA, and also inhibited the growth of both Gram-positive and Gram-negative bacteria in culture. Structure-activity relationship (SAR) studies of the mono-indole and mono-benzofuran inhibitors suggested that the hydrophilic-hydrophobic balance is an important determinant of biological activity. (C) 2015 Elsevier Ltd. All rights reserved.